PMV PHARMACEUTICALS
PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.
PMV PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Medical Device
Founded:
2013-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.pmvpharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
236 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Microsoft Exchange Online Office 365 Mail
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Viking Global Investors
Viking Global Investors investment in Series D - PMV Pharmaceuticals
Nextech Invest
Nextech Invest investment in Series D - PMV Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series D - PMV Pharmaceuticals
Avoro Capital Advisors
Avoro Capital Advisors investment in Series D - PMV Pharmaceuticals
OrbiMed
OrbiMed investment in Series D - PMV Pharmaceuticals
Boxer Capital
Boxer Capital investment in Series D - PMV Pharmaceuticals
Wellington Management
Wellington Management investment in Series D - PMV Pharmaceuticals
InterWest Partners
InterWest Partners investment in Series C - PMV Pharmaceuticals
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series C - PMV Pharmaceuticals
Nextech Invest
Nextech Invest investment in Series C - PMV Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-09-29 | Apitope | PMV Pharmaceuticals investment in Series B - Apitope | 12 M EUR |
| 2013-01-23 | FF Pharma | PMV Pharmaceuticals investment in Series A - FF Pharma | 4 M EUR |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-09 | PMV Pharmaceuticals Appoints Tim Smith as Senior Vice President, Head of Corporate Development |
| 2019-12-11 | PMV Pharma appoints new chief medical officer |
Official Site Inspections
http://www.pmvpharma.com Semrush global rank: 3.55 M Semrush visits lastest month: 4.1 K
- Host name: ec2-34-192-255-123.compute-1.amazonaws.com
- IP address: 34.192.255.123
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "PMV Pharmaceuticals" on Search Engine
Overview | PMV Pharmaceuticals, Inc.
Mar 4, 2024 PMV Pharmaceuticals is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies that target p53 …See details»
PMV Pharmaceuticals - Crunchbase Company Profile
Legal Name PMV Pharmaceuticals, Inc. Stock Symbol NASDAQ:PMVP. Company Type For Profit. Contact Email [email protected]. Phone Number (609) 642-6670. PMV …See details»
PMV Pharmaceuticals Strengthens Leadership with Key …
PRINCETON, N.J., Jan. 05, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and …See details»
PMV Pharmaceuticals Strengthens Leadership with Key …
Jan 5, 2024 PMV Pharmaceuticals, Inc. PC14586 clinical program to be led by Deepika Jalota, Pharm.D. (Chief Development Officer) and Marc Fellous, M.D. (Senior Vice …See details»
PMV Pharmaceuticals, Inc. | LinkedIn
PMV Pharmaceuticals, Inc. Biotechnology Research Plainsboro, New Jersey 3,297 followers Harnessing the power of p53 to treat cancerSee details»
PMV Pharmaceuticals Reports First Quarter 2024 Financial …
The decrease in R&D expenses was primarily related to decreased contractual research organization costs, offset by increased personnel related costs and stock-based …See details»
PMV Pharmaceuticals Reports First Quarter 2024 Financial …
PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and …See details»
PMV Pharmaceuticals Reports Third Quarter 2022 Financial …
CRANBURY, N.J., Nov. 08, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and …See details»
PMV Pharmaceuticals Announces First Patient Dosed in Global …
PRINCETON, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and …See details»
PMV Pharmaceuticals - Org Chart, Teams, Culture & Jobs - The …
PMV Pharmaceuticals - Org Chart, Teams, Culture & Jobs | The Org. 1 follower. ‌. PMV Pharmaceuticals, Inc. is developing first-in-class p53 regulators for the treatment of …See details»
2024-05-09 | NDAQ:PMVP | Press Release | PMV …
Mar 31, 2023 Cash, cash equivalents, and marketable securities of $213.1 million as of March 31, 2024, providing expected cash runway to end of 2026. PRINCETON, N.J., …See details»
PMV Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical …
Apr 1, 2024 Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with a …See details»
PMV Pharmaceuticals, Inc. - AnnualReports.com
PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53. p53 mutations are found in …See details»
PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2021 …
PMV Pharma ended the fourth quarter with $314.1 million in cash, cash equivalents, and marketable securities, compared to $361.4 million as of December 31, 2020. Net cash …See details»
PMV Pharmaceuticals, Inc. Stock - MarketScreener.com
PMV Pharmaceuticals, Inc. is a precision oncology company, which is engaged in discovery and development of small molecule, tumor-agnostic therapies targeting p53. …See details»
Executive Director, Head of Regulatory Affairs | PMV
The candidate will be responsible for working with global health authorities to appropriately position PMV’s innovative products while also ensuring efficient and compliant internal …See details»
PMV Pharmaceuticals, Inc. (PMVP) - Yahoo Finance
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights. Registrational, tumor-agnostic Phase 2 portion of PYNNACLE clinical trial of rezatapopt …See details»
PMV Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. PMV Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles …See details»
PMV Pharmaceuticals: Virtual KOL Event to review Phase 1 …
Oct 12, 2023 PMV Pharmaceuticals management will provide details on the PC14586 development program as well as a regulatory update. A live question and answer …See details»
Craig-Hallum Initiates Coverage of PMV Pharmaceuticals (PMVP …
2 days ago As of May 8, 2024, the average one-year price target for PMV Pharmaceuticals is 8.92. The forecasts range from a low of 5.05 to a high of $18.90. …See details»